Health Canada, Canada
Senior Scientific Evaluator
Dr. Gloria Giraldo is a Microbiologist, Master in Epidemiology from the University of Antioquia, Colombia; a Nurse Specialist in Oncology, from the University of Buffalo, U.S.A; Specialist in Burden of the Disease from the University of Harvard, U.S.A. Dr. Giraldo has international experience in oncology research, epidemiology of infectious diseases, pharmacoepidemiology and pharmacovigilance. Currently, she is a Senior Scientific Evaluator at the Marketed Health Products Directorate of Health Canada in Ottawa, Canada.
Dr. Giraldo has experience coordinating and conducting clinical trials, including analysis of quality of life; in pharmacoepidemiology, and in pharmacovigilance of commercialized products, including the evaluation of risk management plans; the application of methodologies for risk-benefit assessment and in the application of methods for health research and risk communication. Currently, Dr. Giraldo works mainly in the pharmacovigilance of vaccines, rare diseases, and vaccines/therapies related to COVID-19, and provides technical support to the Pharmacovigilance Network of the Pan American Health Organization, the Uppsala Monitoring Center (UMC) and the International Society of Pharmacovigilance (ISoP) and serves as a member of the WHO’s Expert Advisory Panel on Medicine Safety.